Physician profile
Carrie Pedersen
NPI 1093203861
$2,103.05
in general payments reported to CMS, 2019-2025
24 companies · $18.03 in 2025
The $18.03 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,199 · 2022: $848 · 2023: $37.44 · 2025: $18.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $686.28 | 2021-2025 | |
| Amarin Pharma, INC. | $209.60 | 2021-2022 | |
| Novo Nordisk INC | $204.21 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.50 | 2021-2022 | |
| Amgen INC. | $93.64 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $70.27 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $68.11 | 2022 | |
| Merck Sharp & Dohme LLC | $66.44 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $65.40 | 2021 | |
| Lilly USA, LLC | $61.14 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $54.91 | 2021 | |
| Glaxosmithkline, LLC. | $54.21 | 2021-2022 | |
| Antares Pharma, INC. | $51.68 | 2021 | |
| Sunovion Pharmaceuticals INC. | $49.30 | 2021-2022 | |
| Abbott Laboratories | $37.88 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.46 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $33.77 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.59 | 2022 | |
| Pfizer INC. | $17.22 | 2022 | |
| Cranial Technologies, INC | $15.85 | 2021 | |
| Mylan Specialty L.P. | $15.03 | 2022 | |
| Genentech USA, INC. | $13.87 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.35 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Pedersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.